FDA Approved: DEFEROXAMINE MESYLATE — Supplemental Application (Hospira, Inc.)

View source ↗

Summary

FDA approves a supplemental application for deferoxamine mesylate (Hospira) under ANDA076019.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Iron Overload
• Iron Poisoning

Drugs mentioned

• Deferoxamine Mesylate (Deferoxamine)

Snippet

SUPPL AP for DEFEROXAMINE MESYLATE (DEFEROXAMINE MESYLATE)